Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic parkinsonism treated with bromocriptine.

P F Teychenne, P N Leigh, J L Reid

    Lancet (London, England)
    |September 13, 1975
    PubMed
    Summary

    Bromocriptine, a dopamine-simulating drug, showed significant therapeutic benefits for idiopathic parkinsonism patients. While adverse effects were noted, many patients reduced or stopped levodopa treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparison of Histopathologic Features of Right and Left Sided Colon Cancer.

    ANZ journal of surgery·2026
    Same author

    Expression of growth mediators in the gingival crevicular fluid of patients with aggressive periodontitis undergoing periodontal surgery.

    Clinical oral investigations·2018
    Same author

    Clinical outcomes of a vitrified donor oocyte programme: A single UK centre experience.

    European journal of obstetrics, gynecology, and reproductive biology·2018
    Same author

    Career satisfaction and work-life balance of specialist orthodontists within the UK/ROI.

    British dental journal·2017
    Same author

    Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.

    Oral diseases·2017
    Same author

    Prevalence and treatment of necrotizing ulcerative gingivitis (NUG) in the British Armed Forces: a case-control study.

    Clinical oral investigations·2016

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Neurology

    Background:

    • Idiopathic parkinsonism is a neurodegenerative disorder affecting motor function.
    • Dopamine deficiency is a key characteristic of parkinsonism.
    • Levodopa is a common treatment, but can have limitations.

    Purpose of the Study:

    • To evaluate the efficacy and toxicity of bromocriptine in patients with idiopathic parkinsonism.
    • To compare bromocriptine's therapeutic response against placebo.
    • To assess bromocriptine's impact on existing levodopa therapy.

    Main Methods:

    • A double-blind, within-patient study design was employed.
    • Twenty-eight patients with idiopathic parkinsonism participated.
    • Maximum tolerated doses of bromocriptine were compared to placebo.

    Related Experiment Videos

    Main Results:

    • Bromocriptine demonstrated a substantial and statistically significant therapeutic response.
    • Adverse reactions were dose-dependent, reversible, and comparable to levodopa.
    • Fourteen patients discontinued levodopa; five had their dosage reduced.

    Conclusions:

    • Bromocriptine is an effective treatment option for idiopathic parkinsonism.
    • It offers a potential alternative or adjunct to levodopa therapy.
    • Careful dosage titration is necessary due to potential side effects.